Vaccine innovation model: A technology transfer perspective in pandemic contexts

This work identifies the innovations that made it possible for the Bio-Manguinhos/Fiocruz Immunobiological Technology Institute to engage in the entire production of the Oxford/AstraZeneca vaccine (ChAdOx1 nCov-19) in Brazil, just 1.8 years after the COVID-19 pandemic was declared. The results were summarized in a case-based innovation model composed of 11 workstreams, 32 stages, 22 gates, 11 innovations, and 38 events. In terms of research contributions, three were found: (i) the identification of firm and government-level innovations allowing the substantial reduction in the COVID-19 vaccine time-to-market in Brazil; (ii) the presentation of empirical evidence supporting the new Outbreak Paradigm for vaccine research, development, and production; and (iii) the proposition of a conceptual model for describing innovations through the vaccine value chain in pandemic contexts, particularly when technology transfer is involved.     

Innovating medication reviews through a technology-enabled process

Medication reviews are effective in improving the quality of medication use among older people. However, they are conducted to various standards resulting in a wide range of outcomes which limit generalisability of findings arising from research studies. There also appear to be funding and time constraints, lack of data storage for quality improvement purposes, and non-standardised reporting of outcomes, especially clinically relevant outcomes. Furthermore, the coronavirus disease-19 (COVID-19) pandemic has restricted many face-to-face activities, including medication reviews. This article introduces a technology-enabled approach to medication reviews that may overcome some limitations with current medication review processes, and also make it possible to conduct medication reviews during the COVID-19 pandemic by providing an alternate platform. The possible advantages of this technology-enabled approach, legislative considerations and possible implementation in practice are discussed.     

科技期刊嵌入的多重复合科技创新生态系统研究

【目的】 深入探究科技期刊和科技创新生态系统的关系,为科技期刊响应国家号召,高质量、可持续地服务科技创新提供参考。【方法】 基于生态隐喻和模型构建法,构造出科技期刊嵌入的多重复合科技创新生态系统模型,理顺期刊创新运作机制和复合系统构建路径。【结果】 科技期刊被嵌入科技创新生态系统后,形成身兼二任的次生生态,不仅是创新成果作者与多种科技创新主体的接口,而且上下联通不同层级创新生态圈,还衍生出动态自调节、协同共生、交互作用机制。【结论】 科技期刊强力嵌入并高效发挥主观能动性,为科技期刊服务国家科技创新提供全新理论和实践动力,并丰富科技创新生态系统层次、内涵。     

医学院校卫生信息管理专业创新创业"生态圈"模式构建的思考

本文分析了医学院校卫生信息管理专业创新创业人才培养模式的现状；阐述了医学院校卫生信息管理专业创新创业"生态圈"建设的基本思路；论述了如何在大数据与人工智能背景下，构建以"大数据与人工智能创新创业平台"为中心，以医学院及其附属医院、医疗相关企业、技术公司为主体，以创业学院、创业实验室、创新工作室、创业公司为组织形式的创新创业人才培养"生态圈"。在这"生态圈"中，组织在学生成长的不同阶段逐渐分享利益、资源和发展。     

校友资源在高校大学生创新创业教育发展中的情况调查研究

为研究校友资源在高校大学生创新创业教育发展中情况,采用个案调查方法对校友资源在大学生创新创业教育发展中情况进行调查,调查内容涉及影响大学生创新创业意识、动机、教育培养、校友资源运用等多个方面,调查结果运用SPASS软件进行统计分析,最后从高校校友资源角度对高校大学生创新创业发展提出意见建议,以期为高校校友资源在高校创新创业教育发展中提供借鉴和参考。     

Local Leaders' Perspectives on Women Veterans’ Health Care: What Would Ideal Look Like?

Background

The Veterans Health Administration (VHA) faces challenges in providing comprehensive, gender-sensitive care for women. National policies have led to important advancements, but local leadership also plays a vital role in implementing changes and operationalizing national priorities. In this article, we explore the notions of ideal women veterans' health care articulated by women's health leaders at local VHA facilities and regional networks, with the goal of identifying elements that could inform practice and policy.